Aquestive Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-57.2M | $9.2M |
| FY2017 | — | $-26.5M | $17.4M |
| FY2018 | — | $10.1M | $60.6M |
| FY2019 | $70.0M | $-6.1M | $49.3M |
| FY2020 | $51.5M | $-48.5M | $31.8M |
| FY2021 | — | $-82.1M | $28.0M |
| FY2022 | $33.4M | $-118.6M | $27.3M |
| FY2023 | $45.0M | $-106.5M | $23.9M |
| FY2024 | $45.0M | $-60.2M | $71.5M |
| FY2025 | $45.0M | $-33.7M | $121.2M |